Safety of sputum induction in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 399s Year: 2003
Safety and efficacy of sputum induction in COPD patients Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education Year: 2013
Safety of sputum induction Source: Eur Respir J 2002; 20: 9S-18S Year: 2002
Efficacy of the using budesonide/formoterol in patients with bronchial asthma (BA): the study of routine clinical practice Source: Eur Respir J 2006; 28: Suppl. 50, 499s Year: 2006
Sputum induction in asthmatic children: safety in children and feasibility of new methods of monitoring inflammation in sputum samples Source: Eur Respir J 2006; 28: Suppl. 50, 259s Year: 2006
Interleukine-13 in induced sputum in clinical remission asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 175s Year: 2003
Safety and tolerability of differing sputum induction methods in normal subjects Source: Eur Respir J 2002; 20: Suppl. 38, 542s Year: 2002
Clinical use of induced sputum in the management of asthma. A noninvasive measurements of airway Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007
Safety of airway clearance techniques, sputum induction and bronchoscopy in severe asthma Source: International Congress 2017 – Bronchial asthma management Year: 2017
The use of induced sputum in clinical trials Source: Eur Respir J 2002; 20: 47S-50S Year: 2002
Safety of formoterol in asthma clinical trials Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012
Clinical applications of assessment of airway inflammation using induced sputum Source: Eur Respir J 2002; 20: 40S-43S Year: 2002
Monitoring of sputum eosinophils in long-term treatment of bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002
Patients’ perception of allergic asthma and their compliance to omalizumab in an Italian clinical setting Source: International Congress 2017 – Asthma management Year: 2017
Clinical application of induced sputum Source: Annual Congress 2008 - Biomarkers in COPD - application in clinical and epidemiological studies Year: 2008
Clinical review of long-term pranlukast therapy in adult patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 310s Year: 2004
Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice Source: ERJ Open Res, 4 (4) 00049-2018; 10.1183/23120541.00049-2018 Year: 2018
A randomized phase 3 study of the efficacy and safety of reslizumab in subjects with asthma with elevated eosinophils Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014
Safety of formoterol in children and adolescents: experience from asthma clinical trials Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008